1 / 10

Addressing Depression in “Medicare Health Support”

Addressing Depression in “Medicare Health Support”. Michael Schoenbaum June 27, 2005. Collaboration between RAND, University of Washington, University of Pittsburgh Harold Pincus (co-PI) Jürgen Unützer Wayne Katon Funded by National Institute of Mental Health (1 R01 MH75159-01)

kyros
Download Presentation

Addressing Depression in “Medicare Health Support”

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Addressing Depression in “Medicare Health Support” Michael Schoenbaum June 27, 2005

  2. Collaboration between RAND, University of Washington, University of Pittsburgh • Harold Pincus (co-PI) • Jürgen Unützer • Wayne Katon • Funded by • National Institute of Mental Health (1 R01 MH75159-01) • John A. Hartford Foundation • Robert Wood Johnson Foundation

  3. Introduction • Medicare Modernization Act of 2003 (Section 721) created “Chronic Care Improvement Program” • New care management benefit under FFS Medicare • Phase 1 is 3-year pilot program • Complex diabetes and/or congestive heart failure • Medicare risk score of “moderate” or higher • 9 sites - each set up as randomized control trial • Up to 20,000 intervention & 10,000 control patients • Participation is voluntary

  4. 9 Sites in Phase 1 • Florida (Central) – Humana & Pfizer Health Solutions • Tennessee - XLHealth Corp. • Illinois (Chicago) - Aetna Health Management • Oklahoma - Lifemasters Supported SelfCare • Mississippi - McKesson Health Solutions • Georgia - CIGNA HealthCare • Pennsylvania (Western)- Health Dialog Services Corp. • Maryland & Washington DC - American Healthways • New York (Queens & Brooklyn) - Visiting Nurse Service of New York Home Care & United HealthCare Services

  5. Introduction (cont.) • Organizations develop & apply own disease management protocols • Who to target • What services to provide • CMS can’t mandate content • CMS will judge organizations based on • Cost: total Medicare costs must be <95% of usual care • Performance indicators, e.g., HbA1c, flu vaccine, depression screening

  6. Why focus on comorbid depression? • Prevalent in CCIP population • Up to 25% in Medicare patients with diabetes/CHF • Associated with higher costs & worse outcomes • >2x health costs • ~2x mortality • More diabetes & CHF complications • Higher disability • Impairs compliance with treatment • Lower medication adherence • Less likely to improve diet, exercise, smoking cessation

  7. Diagnosis Care manager Proactive tracking & reminders Benchmarking & stepped care Patient education Behavioral activation Medication management Brief psychotherapy Psychiatric consultation How to address depression • Usual care for depression not effective or cost-effective • Effective strategies exist, based on “collaborative care” model

  8. Our project • Technical assistance to organizations, to help them • Manage and track depression in their patient populations • Provide web-based “depression toolkit” • Craft a customized depression care program • Train their staff • Evaluate effectiveness • Work with CMS to evaluate • Role of depression as moderator of program effectiveness • Value-added of specific strategies to address comorbid depression

  9. Timeline

More Related